HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sukru Oter Selected Research

Sukru Oter Research Topics

Disease

9Inflammation (Inflammations)
07/2012 - 05/2005
7Cystitis
09/2007 - 12/2003
5Hemorrhagic Cystitis
09/2007 - 12/2003
3Acute Necrotizing Pancreatitis
09/2011 - 01/2010
2Necrosis
07/2012 - 05/2005
2Reperfusion Injury
02/2011 - 08/2009
2Ischemia
02/2011 - 08/2009
2Sepsis (Septicemia)
01/2011 - 09/2005
2Wounds and Injuries (Trauma)
01/2011 - 10/2010
2Metabolic Diseases (Metabolic Disease)
12/2009 - 01/2009
1Poisoning
02/2015
1Colitis
05/2011
1Lung Injury
01/2011
1Cardiotoxicity
01/2011
1Pancreatitis
09/2010
1Neoplasms (Cancer)
12/2009
1Lung Diseases (Lung Disease)
12/2009
1Glucocorticoid Receptor Deficiency
12/2009
1Chronic Disease (Chronic Diseases)
12/2009
1Necrotizing Enterocolitis
03/2009
1Hypoxia (Hypoxemia)
03/2009
1Hyperglycemia
10/2008
1Nephrosis
01/2006
1Weight Gain
01/2006
1Nephrotic Syndrome (Syndrome, Nephrotic)
01/2006
1Edema (Dropsy)
01/2006
1Proteinuria
01/2006
1Body Weight (Weight, Body)
07/2005

Drug/Important Bio-Agent (IBA)

8Oxygen (Dioxygen)IBA
02/2015 - 12/2003
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2007 - 12/2003
5OzoneIBA
07/2012 - 01/2010
5AntioxidantsIBA
12/2009 - 11/2004
5Oxidants (Oxidizing Agents)IBA
09/2007 - 11/2004
4MelatoninIBA
01/2011 - 05/2005
3Atrial Natriuretic Factor (ANF)IBA
09/2011 - 01/2010
3Malondialdehyde (Propanedial)IBA
01/2011 - 05/2005
3Peroxynitrous Acid (Peroxynitrite)IBA
12/2009 - 05/2005
3CytokinesIBA
12/2009 - 05/2005
3Mesna (Coenzyme M)FDA LinkGeneric
09/2007 - 11/2004
3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
05/2005 - 12/2003
3Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2005 - 12/2003
2NeopterinIBA
07/2012 - 09/2010
2salicylhydroxamic acid (SHAM)IBA
01/2011 - 01/2006
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2011 - 01/2006
2Transcription Factors (Transcription Factor)IBA
12/2009 - 01/2009
2Reactive Oxygen Species (Oxygen Radicals)IBA
08/2005 - 05/2005
2NitratesIBA
07/2005 - 05/2005
1Carbon MonoxideIBA
02/2015
1Acetaminophen (Paracetamol)FDA LinkGeneric
07/2012
1Therapeutic UsesIBA
09/2011
1S-methylisothiopseudouroniumIBA
09/2011
1Tadalafil (Cialis)FDA Link
02/2011
1Sildenafil Citrate (Viagra)FDA Link
02/2011
1Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
02/2011
1Cefepime (Maxipime)FDA LinkGeneric
01/2011
1Trastuzumab (Herceptin)FDA Link
01/2011
1N- ((3- (aminomethyl)phenyl)methyl)ethanimidamideIBA
01/2011
12-mercaptoethylguanidineIBA
01/2011
1Protective AgentsIBA
01/2011
1acetamidineIBA
01/2011
1hydroxide ionIBA
10/2010
1benzamideIBA
09/2010
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
09/2010
1Taurocholic Acid (Sodium Taurocholate)IBA
01/2010
1erdosteineIBA
08/2009
1ebselenIBA
08/2009
1NitrogenIBA
08/2009
1VitaminsIBA
01/2009
1Hazardous Substances (Hazardous Materials)IBA
10/2008
1indolamineIBA
10/2008
1Angiotensin Receptor AntagonistsIBA
01/2006
1Biomarkers (Surrogate Marker)IBA
01/2006
1Losartan (Cozaar)FDA LinkGeneric
01/2006
1gallocatechol (epigallocatechin)IBA
08/2005
1QuercetinIBA
08/2005
1FlavonoidsIBA
08/2005
1EnzymesIBA
07/2005
1Drinking WaterIBA
07/2005
1Nitric Oxide Synthase (NO Synthase)IBA
05/2005
1Antineoplastic Agents (Antineoplastics)IBA
05/2005
1NitritesIBA
05/2005

Therapy/Procedure

9Therapeutics
02/2015 - 09/2005
3Hyperbaric Oxygenation
01/2010 - 12/2003
2Intraperitoneal Injections
01/2011 - 09/2005
2Anesthesia
10/2010 - 01/2006
1Topical Administration
10/2010
1Pinealectomy
10/2010